Medical devices, healthcare technology and the business of care
510(k) clearance · K253406

S250-FIT Proton Beam Radiation Therapy Device (S250-FIT)

Mevion Medical Systems, Inc. · Decision date Mar 25, 2026

FDA DECISIONK253406

What did the FDA decide?

FDA records K253406 as a 510(k) premarket notification, with a decision dated Mar 25, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Mar 25, 2026

FDA source record

Regulatory record facts

Identifier
K253406
Regulatory pathway
510(k) premarket notification
Product code
LHN
Decision code
SESE
Decision date
Mar 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Radiation Therapy, Charged-Particle, Medical.

Product code
LHN
FDA device class
2

FDA decision timeline

  1. K253406 received

    Application receipt date recorded by FDA.

  2. K253406 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LHN

Product / regulatory recordCompanyPathwayDecision dateSource
VIRTUE QAK260597
ProNova Solutions510(k) clearanceSep 23, 2026FDA
PROBEAT-CRK260174
Hitachi High-Tech Corp.510(k) clearanceJun 11, 2026FDA
Varian Medical Systems, Inc.510(k) clearanceApr 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mevion Medical Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Littleton, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records